162 related articles for article (PubMed ID: 10022248)
1. Functional consequences of polymorphism of xenobiotic metabolising enzymes.
Ingelman-Sundberg M
Toxicol Lett; 1998 Dec; 102-103():155-60. PubMed ID: 10022248
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability in susceptibility and response to toxicants.
Ingelman-Sundberg M
Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of cytochrome P450 and xenobiotic toxicity.
Ingelman-Sundberg M
Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
[TBL] [Abstract][Full Text] [Related]
4. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
5. Some aspects of interindividual variations in the metabolism of xenobiotics.
Tamási V; Vereczkey L; Falus A; Monostory K
Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
[TBL] [Abstract][Full Text] [Related]
6. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
Ingelman-Sundberg M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
[TBL] [Abstract][Full Text] [Related]
7. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
Schulz T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
[TBL] [Abstract][Full Text] [Related]
8. Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.
Rekka EA; Kourounakis PN; Pantelidou M
Curr Top Med Chem; 2019; 19(4):276-291. PubMed ID: 30706817
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in xenobiotic metabolism.
Smith CA; Smith G; Wolf CR
Eur J Cancer; 1994; 30A(13):1921-35. PubMed ID: 7734203
[No Abstract] [Full Text] [Related]
11. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication.
Tang X; Chen S
Curr Drug Metab; 2015; 16(2):86-96. PubMed ID: 26179605
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.
Ingelman-Sundberg M
Mutat Res; 2001 Oct; 482(1-2):11-9. PubMed ID: 11535244
[TBL] [Abstract][Full Text] [Related]
14. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
15. The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics.
Ingelman-Sundberg M
Arch Toxicol Suppl; 1997; 19():3-13. PubMed ID: 9079190
[No Abstract] [Full Text] [Related]
16. Implications of polymorphic cytochrome p450-dependent drug metabolism for drug development.
Ingelman-Sundberg M
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):570-3. PubMed ID: 11259354
[TBL] [Abstract][Full Text] [Related]
17. Comparison of xenobiotic-metabolising human, porcine, rodent, and piscine cytochrome P450.
Burkina V; Rasmussen MK; Pilipenko N; Zamaratskaia G
Toxicology; 2017 Jan; 375():10-27. PubMed ID: 27884721
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 and xenobiotic receptor humanized mice.
Gonzalez FJ; Yu AM
Annu Rev Pharmacol Toxicol; 2006; 46():41-64. PubMed ID: 16402898
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Reszka E; Wasowicz W; Gromadzinska J
Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
Kiyohara C
J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
